References
- Bain J, Grover P K., Swerdloff R S., Odell W D. One column chromatography and simultaneous radioimmunoassay of T and DHT. J Steroid Biochem 1974; 5: 304A40
- Caraceni T, Panerai A E., Parati E A., Cocchi D, Muller E E. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's Chorea. J Clin Endocrinol Metab 1977; 44: 870–875
- Chambers J W., Brown G M. Neurotransmitter regulation of growth hormone and ACTH in the Rhesus monkey: effects of biogenic amines. Endocrinology 1976; 98: 420–428
- Chiodini P G., Liuzzi A, Botalla L, Oppizzi G, Muller E E., Silvestrini F. Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-α-ergocryptine (CB-154) in acromegalic patients. J Clin Endocrinol Metab 1975; 40: 704–708
- Corrodi H, Fuxe K, Hokfelt T, Lidbrink P, Ungerstedt U. Effects of ergot drugs on central neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol 1973; 25: 409–412
- DiChiara G, Porceddu M L., Vargin L, Stefanini E, Gessa G L. Evidence for selective and long-lasting stimulation of “regulatory” dopamine-receptors by bromocriptine (CB-154). Naunyn-Schmiedeberg's Arch Pharmacol 1977; 300: 239–245
- Holland F J., Richards G E., Kaplan S L., Ganong W F., Grumbach M M. The role of biogenic amines in the regulation of growth hormone and adrenocorticotrophic hormone secretion in the trained conscious dog. Endocrinology 1978; 102: 1452–1457
- Johnson A M., Loew D M., Vigouret J M. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomor-phine, (+)-amphetamine and L-dopa. Br J Pharmacol 1976; 56: 59–68
- Klugh H E. Statistics: the essentials for research. John Wiley and Sons, New York 1970
- Lamberts S WJ, Birkenhager J C. Effect of bromocriptine in pituitary-dependent Cushing's Syndrome. J Endocrinol 1976; 70: 315–316
- Odell W D., Swerdloff R S., Bain J, Wollesen F, Grover P K. The effect of sexual maturation of testicular response to LH stimulation on testosterone secretion in the intact rat. Endocrinology 1974; 95: 1380–1384
- MacLeod R M. Regulation of prolactin secretion. Frontiers in Neuroendocrinology, L Martini, W F. Ganong. Raven Press, New York 1976; Vol 4: 169–194
- Murphy B EP. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab 1967; 27: 973–990
- Rees L H., Cook D M., Kendall J W., Allen C F., Kramer R M., Ratcliffe J D., Knight R A. A radioimmunoassay for rat plasma ACTH. Endocrinology 1971; 89: 254–261
- Thorner M O., McNeilly A S., Hagan C, Besser G M. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Brit Med J 1974; 2: 419–422
- Tolis G, Pinter E J., Friesen H G. The acute effect of 2-bromo-α-ergocriptine (CB-154) on anterior pituitary hormones and free fatty acids in man. Int J Clin Biopharmacol 1975; 12: 281–283
- Van Loon G R. Brain catecholamines and ACTH secretion. Frontiers in Neuroendocrinology, W F. Ganong, L L. Martini. Oxford University Press, New York 1973; 209–247, 1973
- Van Loon G R. Bromocriptine-induced inhibition of plasma dopamine, noradrenaline and adrenaline responses to LH-RF. Nature 1978; 275: 331–332
- Van Loon G R., Kim C. Corticosterone modulation of nigroneostriatal and tuberoinfundib-ular dopamine neurons to receptor blockade. Ann Meet Soc Neuroscience Abstracts 1977; 3: 262
- Van Loon G R., Sole M J., Bain J, Ruse J. Effects of bromocriptine on plasma catecholamines in normal men. Neuroendocrinology 1979; 28: 425–434